Abstract
This document presents the guidelines for anti-ganglioside antibody testing that have been developed following a consensus process built on questionnaire-based surveys, internet contacts, and discussions at workshops of the sponsoring Italian Association of Neuroimmunology (AINI) congresses. Main clinical information on dysimmune peripheral neuropathies, indications and limits of anti-ganglioside antibody testing, instructions for result interpretation, and an agreed laboratory protocol (Appendix) are reported for the communicative community of neurologists and clinical pathologists.
Original language | English |
---|---|
Pages (from-to) | 243-247 |
Number of pages | 5 |
Journal | Neurological Sciences |
Volume | 38 |
Issue number | Suppl 2 |
DOIs | |
Publication status | Published - Oct 2017 |
Keywords
- Journal Article
- Review